Cargando…

Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα

Phenotypic screening of α-substituted thiocarbohydrazones revealed promising activity of 1,5-bis(salicylidene)thiocarbohydrazide against leukemia and breast cancer cells. Supplementary cell-based studies indicated an impairment of DNA replication via the ROS-independent pathway. The structural simil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cvijetić, Ilija N., Herlah, Barbara, Marinković, Aleksandar, Perdih, Andrej, Bjelogrlić, Snežana K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054454/ https://www.ncbi.nlm.nih.gov/pubmed/36986441 http://dx.doi.org/10.3390/ph16030341

Ejemplares similares

Unveiling the interdomain dynamics of type II DNA topoisomerase through all-atom simulations: Implications for understanding its catalytic cycle
por: Pavlin, Matic, et al.
Publicado: (2023)

Catalytic Mechanism of ATP Hydrolysis in the ATPase Domain of Human DNA Topoisomerase IIα
por: Ogrizek, Mitja, et al.
Publicado: (2022)

Substituted 4,5′-Bithiazoles as Catalytic Inhibitors of Human DNA Topoisomerase IIα
por: Bergant Loboda, Kaja, et al.
Publicado: (2020)

Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα
por: Janežič, Matej, et al.
Publicado: (2021)

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
por: Matias-Barrios, Victor M., et al.
Publicado: (2021)

Biological Applications of Thiocarbohydrazones and Their Metal Complexes: A Perspective Review
por: Bonaccorso, Carmela, et al.
Publicado: (2019)

Conformational Properties of New Thiosemicarbazone and Thiocarbohydrazone Derivatives and Their Possible Targets
por: Georgiou, Nikitas, et al.
Publicado: (2022)

A New Photoactivatable Ruthenium(II) Complex with an Asymmetric Bis-Thiocarbohydrazone: Chemical and Biological Investigations
por: Pioli, Marianna, et al.
Publicado: (2021)

Non-Catalytic Roles of the Topoisomerase IIα C-Terminal Domain
por: Clarke, Duncan J., et al.
Publicado: (2017)

Synthesis and Antimycobacterial Activity of Symmetric Thiocarbohydrazone Derivatives against Mycobacterium bovis BCG
por: Haj Mohammad Ebrahim Tehrani, Kamaleddin, et al.
Publicado: (2013)

HMGB1 interacts with human topoisomerase IIα and stimulates its catalytic activity
por: Štros, Michal, et al.
Publicado: (2007)

Evaluation of Firefly and Renilla Luciferase Inhibition in Reporter-Gene Assays: A Case of Isoflavonoids
por: Kenda, Maša, et al.
Publicado: (2021)

Anticancer Activity of Indeno[1,2-b]-Pyridinol Derivative as a New DNA Minor Groove Binding Catalytic Inhibitor of Topoisomerase IIα
por: Jeon, Kyung-Hwa, et al.
Publicado: (2021)

Thiocarbohydrazone and Chalcone-Derived 3,4-Dihydropyrimidinethione as Lipid Peroxidation and Soybean Lipoxygenase Inhibitors
por: Georgiou, Nikitas, et al.
Publicado: (2023)

Catalytic Core of Human Topoisomerase IIα: Insights into Enzyme–DNA Interactions and Drug Mechanism
por: Lindsey, R. Hunter, et al.
Publicado: (2014)

Exploration of the Role of the C-Terminal Domain of Human DNA Topoisomerase IIα in Catalytic Activity
por: Dougherty, Ashley C., et al.
Publicado: (2021)

Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CL(pro) Main Protease
por: Herlah, Barbara, et al.
Publicado: (2022)

QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα
por: Alam, Sarfaraz, et al.
Publicado: (2014)

Molecular docking analysis of α-Topoisomerase II with δ-Carboline derivatives as potential anticancer agents
por: Ayyamperumal, Selvaraj, et al.
Publicado: (2021)

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
por: Molinaro, Caroline, et al.
Publicado: (2020)

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin
por: Jong, R S de, et al.
Publicado: (1999)

Regulation of the catalytic function of topoisomerase II alpha through association with RNA
por: Park, Seung-Won, et al.
Publicado: (2008)

Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy
por: Matias-Barrios, Victor M., et al.
Publicado: (2021)

Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II
por: Hawtin, Rachael E., et al.
Publicado: (2010)

Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
por: Kozuki, Toshiyuki, et al.
Publicado: (2017)

Pt(II)-Thiocarbohydrazone Complex as Cytotoxic Agent and Apoptosis Inducer in Caov-3 and HT-29 Cells through the P53 and Caspase-8 Pathways
por: Ibrahim, Abeer A., et al.
Publicado: (2021)

Natural Products as Topoisomerase II Poisons: Effects of Thymoquinone on DNA Cleavage Mediated by Human Topoisomerase IIα
por: Ashley, Rachel E., et al.
Publicado: (2014)

On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
por: Wu, Chyuan-Chuan, et al.
Publicado: (2013)

A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents
por: Okoro, Cosmas O., et al.
Publicado: (2023)

Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers
por: Boot, Arnoud, et al.
Publicado: (2022)

Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells
por: Vavrova, Anna, et al.
Publicado: (2013)

Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase II α gene transfer is independent of topoisomerase II β
por: Zhou, Z, et al.
Publicado: (2001)

A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity
por: Li, Zhi-Ying, et al.
Publicado: (2021)

Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade
por: Dey, Dipta, et al.
Publicado: (2022)

DNA topoisomerases as molecular targets for anticancer drugs
por: Buzun, Kamila, et al.
Publicado: (2020)

Topoisomerase IIα in Chromosome Instability and Personalized Cancer Therapy
por: Chen, Tao, et al.
Publicado: (2014)

Structural basis for allosteric regulation of Human Topoisomerase IIα
por: Vanden Broeck, Arnaud, et al.
Publicado: (2021)

Dynamics of human DNA topoisomerases IIα and IIβ in living cells
por: Christensen, Morten O., et al.
Publicado: (2002)

Enhanced Topoisomerase I Activity and Increased Topoisomerase IIα Content in Cisplatin‐resistant Cancer Cell Lines
por: Minagawa, Yukihisa, et al.
Publicado: (1997)

Cell Cycle–coupled Relocation of Types I and II Topoisomerases and Modulation of Catalytic Enzyme Activities
por: Meyer, Kay N., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_jp50io68tot3vsjd4oplmn5425